Mostrar el registro sencillo del ítem
| Autor | Souza, Claudia Teresa Vieira de | |
| Autor | Hökerberg, Yara Hahr Marques | |
| Autor | Pacheco, Sandro Javier Bedoya | |
| Autor | Rolla, Valéria Cavalcanti | |
| Autor | Passos, Sonia Regina Lambert | |
| Fecha de acceso | 2019-12-27T14:25:50Z | |
| Fecha de disponibilización | 2019-12-27T14:25:50Z | |
| Fecha de publicación | 2009 | |
| Referencia | SOUZA, Claudia Teresa Vieira de et al. Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 104, n. 3, p. 462-467, May 2009. | pt_BR |
| ISSN | 0074-0276 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/38887 | |
| Idioma | eng | pt_BR |
| Editor | Fiocruz/IOC | pt_BR |
| Derechos de autor | open access | pt_BR |
| Título | Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro | pt_BR |
| Tipo del documento | Article | pt_BR |
| DOI | 10.1590/S0074-02762009000300011 | |
| Resumen en Inglés | The clinical and epidemiological characteristics, adverse events, treatment adherence and effectiveness of isoniazid chemoprophylaxis were analyzed in a cohort of 138 tuberculosis/HIV-coinfected patients. An open, nonrandomized, pragmatic prophylactic trial was conducted on adult patients with a normal chest X-ray and positive tuberculin skin test (≥ 5 mm) who received isoniazid chemoprophylaxis (300 mg/day) for six months. The mean of follow up was 2.8 years (SD 1.3). Adherence to chemoprophylaxis was 87.7% (121/138). Only one patient presented tuberculosis after the end of chemoprophylaxis, corresponding to 0.3 cases per 100 persons per year. The relative risk of some adverse effects was 4.6 times higher (95% CI: 1.9-11.5) in patients with positive anti-HCV serology (4/9, 44.4%) compared to those with negative serology (12/129, 9.6%) (p = 0.002). This study provides evidence regarding the effectiveness and safety of a short and self-administered isoniazid regimen. We recommend the implementation of this routine by health service practitioners. | pt_BR |
| Afiliación | Fundação Oswaldo Cruz. Instituto Evandro Chagas. Laboratório de Epidemiologia Clínica. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Afiliación | Fundação Oswaldo Cruz. Instituto Evandro Chagas. Laboratório de Epidemiologia Clínica. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Afiliación | Fundação Oswaldo Cruz. Instituto Evandro Chagas. Laboratório de Epidemiologia Clínica. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Afiliación | Fundação Oswaldo Cruz. Instituto Evandro Chagas. Laboratório de Pesquisa Clínica em Micobacterioses. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Afiliación | Fundação Oswaldo Cruz. Instituto Evandro Chagas. Laboratório de Epidemiologia Clínica. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Palavras clave en Inglês | Tuberculosis | pt_BR |
| Palavras clave en Inglês | Chemoprophylaxis | pt_BR |
| Palavras clave en Inglês | Isoniazid | pt_BR |
| Palavras clave en Inglês | HIV-1 | pt_BR |
| Palavras clave en Inglês | Clinical trial | pt_BR |
| Palavras clave en Inglês | Treatment outcome | pt_BR |
| e-ISSN | 1678-8060 |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
INI - Artigos de Periódicos [3646]